We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.14B
AUM Growth
+$218M
Cap. Flow
+$172M
Cap. Flow %
8.07%
Top 10 Hldgs %
26.01%
Holding
154
New
13
Increased
61
Reduced
17
Closed
10

Top Buys

Rank Stock Value
1
GTT
GTT Communications, Inc.
GTT
+$19.7M
2
ANET icon
Arista Networks
ANET
+$17.8M
3
VRNS icon
Varonis Systems
VRNS
+$17.3M
4
ROP icon
Roper Technologies
ROP
+$16.3M
5
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$15.9M

Top Sells

Rank Stock Value
1
TTD icon
Trade Desk
TTD
+$16.9M
2
TWLO icon
Twilio
TWLO
+$7.85M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.12M
4
LOXO
Loxo Oncology, Inc
LOXO
+$5.96M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$5.72M

Sector Composition

Rank Sector Weight
1 Healthcare 38.18%
2 Technology 17.61%
3 Consumer Discretionary 12.18%
4 Industrials 9.62%
5 Utilities 3.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROP icon
51
Roper Technologies
ROP
$39B
$16.6M 0.78%
+59,000
New +$16.3M
AY
52
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$16.2M 0.76%
827,500
+22,000
+3% +$447K
WVE icon
53
Wave Life Sciences
WVE
$1.13B
$15.2M 0.71%
378,000
-55,500
-13% -$2.33M
CRUS icon
54
Cirrus Logic
CRUS
$6.75B
$15M 0.7%
370,000
– –
AGIO icon
55
Agios Pharmaceuticals
AGIO
$2.2B
$14.6M 0.68%
178,000
-36,000
-17% -$2.78M
HASI icon
56
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.91B
$14.1M 0.66%
724,000
+26,800
+4% +$546K
BPMC
57
DELISTED
Blueprint Medicines
BPMC
$13.8M 0.64%
150,000
– –
VYGR icon
58
Voyager Therapeutics
VYGR
$187M
$13.2M 0.62%
703,425
– –
NBIX icon
59
Neurocrine Biosciences
NBIX
$18B
$12.9M 0.61%
156,000
– –
VMC icon
60
Vulcan Materials
VMC
$37.3B
$12.6M 0.59%
110,000
– –
TWLO icon
61
Twilio
TWLO
$29.2B
$12.5M 0.58%
327,000
-248,000
-43% -$7.85M
MYOV
62
DELISTED
Myovant Sciences Ltd.
MYOV
$12.2M 0.57%
573,553
+21,453
+4% +$327K
VCYT icon
63
Veracyte
VCYT
$4.48B
$11.9M 0.56%
2,133,500
– –
ZGNX
64
DELISTED
Zogenix, Inc.
ZGNX
$10.6M 0.5%
265,000
+97,000
+58% +$3.85M
DOOR
65
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$10.4M 0.49%
170,000
– –
PAYC icon
66
Paycom
PAYC
$7.44B
$10.3M 0.48%
96,000
+77,618
+422% +$7.45M
FENC icon
67
Fennec Pharmaceuticals
FENC
$358M
$8.96M 0.42%
741,175
– –
BHVN
68
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$8.91M 0.42%
346,000
+104,000
+43% +$3.11M
KALV
69
DELISTED
KalVista Pharmaceuticals
KALV
$8.53M 0.4%
900,000
+191,000
+27% +$2M
BOLD
70
DELISTED
Audentes Therapeutics, Inc
BOLD
$8.11M 0.38%
270,000
+45,000
+20% +$1.52M
ARGX icon
71
argenx
ARGX
$56B
$8.04M 0.38%
+100,000
New +$7.55M
TSLA icon
72
Tesla
TSLA
$1.2T
$7.98M 0.37%
450,000
– –
IFRX icon
73
InflaRx
IFRX
$250M
$7.93M 0.37%
275,000
– –
REGN icon
74
Regeneron Pharmaceuticals
REGN
$72.1B
$7.92M 0.37%
23,000
+15,500
+207% +$5.39M
QURE icon
75
uniQure
QURE
$2.57B
$7.87M 0.37%
+335,000
New +$7.31M
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
GA
Greenhaven Associates Purchase, New York $6.07B AUM 11.2% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Eventide Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Eventide Asset Management held 154 positions worth $2.14B, up 11% from $1.92B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $172M of net new capital in Q1 2018, opening 13 new positions and adding to 61 existing holdings. Its largest new stake was Arista Networks: 1,056,000 shares worth $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Trade Desk, an estimated $16.9M trimmed.

  • Eventide Asset Management's largest Q1 2018 buy was Arista Networks: 1,056,000 shares worth $16.9M.
  • Eventide Asset Management added most to GTT Communications, Inc. in Q1 2018, an estimated $19.7M increase.
  • Eventide Asset Management's biggest Q1 2018 reduction was Trade Desk, cutting an estimated $16.9M.
  • Eventide Asset Management fully exited Protagonist Therapeutics in Q1 2018, selling an estimated $5.72M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $2.14B portfolio in Q1 2018.
  • Eventide Asset Management opened 13 new positions and closed 10 in Q1 2018.
  • Eventide Asset Management's portfolio value rose 11% quarter-over-quarter to $2.14B.

Based on Eventide Asset Management's 13F filing for Q1 2018, filed 15 May 2018.